The Dermatologist's Approach to Onychomycosis

被引:15
|
作者
Queller, Jenna N. [1 ]
Bhatia, Neal [2 ]
机构
[1] Harbor UCLA Med Ctr, Torrance, CA 90502 USA
[2] Therapeut Clin Res, Dermatol Clin, San Diego, CA 92123 USA
关键词
onychomycosis; onycholysis; subungual hyperkeratosis; recurrence; maintenance;
D O I
10.3390/jof1020173
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Onychomycosis is a fungal infection of the toenails or fingernails that can involve any component of the nail unit, including the matrix, bed, and plate. It is a common disorder that may be a reservoir for infection resulting in significant medical problems. Moreover, onychomycosis can have a substantial influence on one's quality of life. An understanding of the disorder and updated management is important for all health care professionals. Aside from reducing quality of life, sequelae of the disease may include pain and disfigurement, possibly leading to more serious physical and occupational limitations. Dermatologists, Podiatrists, and other clinicians who treat onychomycosis are now entering a new era when considering treatment options-topical modalities are proving more effective than those of the past. The once sought after concept of viable, effective, well-tolerated, and still easy-to-use monotherapy alternatives to oral therapy treatments for onychomycosis is now within reach given recent study data. In addition, these therapies may also find a role in combination and maintenance therapy; in order to treat the entire disease the practitioner needs to optimize these topical agents as sustained therapy after initial clearance to reduce recurrence or re-infection given the nature of the disease.
引用
收藏
页码:173 / 184
页数:12
相关论文
共 50 条
  • [31] An observational and descriptive study of the epidemiology of and therapeutic approach to onychomycosis in dermatology offices in Brazil
    Di Chiacchio, Nilton
    Suarez, Maria Victoria
    Madeira, Celso Luis
    Loureiro, Walter Refkalefsky
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2013, 88
  • [32] Onychomycosis in Taiwan
    Wang, SH
    Chi, CC
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (08) : 906 - 911
  • [33] Onychomycosis in the US Pediatric Population-An Emphasis on Fusarium Onychomycosis
    Gupta, Aditya K.
    Wang, Tong
    Ravi, Shruthi Polla
    Bakotic, Wayne L.
    PEDIATRIC DERMATOLOGY, 2025, 42 (01) : 47 - 53
  • [34] Drug Delivery to the Nail: Therapeutic Options and Challenges for Onychomycosis
    Barot, Bhavesh S.
    Parejiya, Punit B.
    Patel, Hetal K.
    Mehta, Dharmik M.
    Shelat, Pragna K.
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2014, 31 (06): : 459 - 494
  • [35] A NEW COMBINED DIAGNOSTIC-APPROACH TO CLINICALLY AND MICROSCOPICALLY SUSPECTED ONYCHOMYCOSIS UNPROVED BY CULTURE
    BLECHER, P
    KORTING, HC
    MYCOSES, 1993, 36 (9-10) : 321 - 324
  • [36] Onychomycosis: Old and New
    Bermudez, Narges Maskan
    Rodriguez-Tamez, Giselle
    Perez, Sofia
    Tosti, Antonella
    JOURNAL OF FUNGI, 2023, 9 (05)
  • [37] Investigational drugs for onychomycosis
    Gupta, Aditya K.
    Simpson, Fiona C.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (01) : 97 - 106
  • [38] Update on the management of onychomycosis
    Piraccini, B. M.
    Gtanni, C.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2013, 148 (06): : 633 - 638
  • [39] Efinaconazole in the treatment of onychomycosis
    Lipner, Shari R.
    Scher, Richard K.
    INFECTION AND DRUG RESISTANCE, 2015, 8 : 163 - 172
  • [40] Mycological diagnosis of onychomycosis
    Chabasse, D.
    Pihet, M.
    JOURNAL DE MYCOLOGIE MEDICALE, 2014, 24 (04): : 269 - 278